Afisi S Ismaila (Afisi Ismaila)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 56

Top Topics

Chronic Obstructive Pulmonary Disease

Clinical Practice

Top Venues

International journal of chronic obstructive pulmonary disease

Respiratory research

BMJ open respiratory research

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Claus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, Nils Kossack, Lena M Richter, Jing Claussen, Chris Compton, Stephen G Noorduyn, Afisi S Ismaila, Gema Requena
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Claus F Vogelmeier, Kai-Michael Beeh, Michael Schultze, Nils Kossack, Lena M Richter, Jing Claussen, Chris Compton, Stephen G Noorduyn, Afisi S Ismaila, Gema Requena
Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 25 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 25 (1) (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Kieran J Rothnie, Robert P Wood, Alexandrosz Czira, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif, Chris Compton, Raj Sharma, David M G Halpin, Afisi S Ismaila, Claus F Vogelmeier
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study. BMJ open respiratory research 11 (1) (2024)
Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen, Fraence Hardtstock, Rachel K Knapp, Thomas Wilke, Alexandrosz Czira, Chris Compton, Afisi S Ismaila
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany. International journal of chronic obstructive pulmonary disease 19 (2024)
Alexandrosz Czira, Victoria L Banks, Gema Requena, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B 2 -agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study. BMJ open 14 (2) (2024)
Robyn Kendall, Alan A Martin, Dhvani Shah, Soham Shukla, Chris Compton, Afisi S Ismaila
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK. International journal of chronic obstructive pulmonary disease 18 (2023)
Kieran J Rothnie, Beade Numbere, Steven Gelwicks, Yifei Lu, Raj Sharma, Chris Compton, Afisi S Ismaila, Jennifer Kathleen Quint
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton, Afisi S Ismaila
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Gema Requena, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β 2 -Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Alexandrosz Czira, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Alexandrosz Czira, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Shoko Akiyama, Takeo Ishii, Robert P Wood, Lucinda J Camidge, Hannah Wallis, Thomas Jennison, Rosie A C Wild, Masao Yarita, Kenichi Hashimoto, Kieran J Rothnie, Afisi S Ismaila
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Sneha Purushotham, Ike Iheanacho, Kieran J Rothnie, Chris Compton, Afisi S Ismaila
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review. International journal of chronic obstructive pulmonary disease 18 (2023)
Alexandrosz Czira, Gema Requena, Victoria L Banks, Robert P Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie A C Wild, Chris Compton, Kieran J Rothnie, Felix J F Herth, Jennifer Kathleen Quint, Afisi S Ismaila
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β 2 -Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Afisi S Ismaila
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. International journal of chronic obstructive pulmonary disease 18 (2023)
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respiratory research 24 (1) (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
David M G Halpin, Robyn Kendall, Soham Shukla, Alan A Martin, Dhvani Shah, Dawn Midwinter, Kai-Michael Beeh, Janwillem W H Kocks, Paul W Jones, Chris Compton, Nancy A Risebrough, Afisi S Ismaila
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, François Laliberté, Young Jung, Sean D MacKnight, Marjorie A Stiegler, Mei Sheng Duh
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Gema Requena, Victoria L Banks, Alexandrosz Czira, Robert P Wood, Theo Tritton, Rosie A C Wild, Chris Compton, Maria Duarte, Afisi S Ismaila
Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β 2 -Agonist Dual Therapy in a Primary Care Setting in England. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Afisi S Ismaila, Katrin Haeussler, Alexandrosz Czira, Ji-Hee Youn, Mia Malmenas, Nancy A Risebrough, Jatin Agarwal, Maria Nassim, Raj Sharma, Chris Compton, Claus F Vogelmeier, Meilan K Han, David M G Halpin
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Advances in therapy 39 (9) (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Kieran J Rothnie, Sandra Joksaite, Leah B Sansbury, Chris Compton, Valentina Di Boscio, Afisi S Ismaila
Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
David M G Halpin, Kieran J Rothnie, Victoria L Banks, Alexandrosz Czira, Chris Compton, Robert P Wood, Theo Tritton, Olivia Massey, Rosie A C Wild, Neil G Snowise, Kirill Nikitin, Raj Sharma, Afisi S Ismaila, Claus F Vogelmeier
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Federico Paly, Laura Amanda Vallejo-Aparicio, Alan A Martin, José Luis Izquierdo, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Catarina Abreu, Chandroday Biswas, Afisi S Ismaila
Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Leah B Sansbury, David A Lipson, Chanchal Bains, Glenn A Anley, Kieran J Rothnie, Afisi S Ismaila
Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. International journal of chronic obstructive pulmonary disease 17 (2022)
Victoria Neches, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila, Antoni Sicras Mainar, Aram Sicras-Navarro, Cruz González, Rafael Cuervo, Soham Shukla, Marcos García-Peñuela
Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain. International journal of chronic obstructive pulmonary disease 17 (2022)
Andrea Gabrio, Necdet B Gunsoy, Gianluca Baio, Alan A Martin, Victoria Federico Paly, Nancy Risebrough, David M G Halpin, Dave Singh, Robert A Wise, MeiLan K Han, Fernando J Martinez, Gerard J Criner, Neil Martin, David A Lipson, Afisi S Ismaila
Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial. International journal of chronic obstructive pulmonary disease 17 (2022)
Leah B Sansbury, Chanchal Bains, David A Lipson, Afisi S Ismaila, Sarah H Landis
Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice. International journal of chronic obstructive pulmonary disease 16 (2021)
Leah B Sansbury, Kieran J Rothnie, Chanchal Bains, Chris Compton, Glenn Anley, Afisi S Ismaila
Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. International journal of chronic obstructive pulmonary disease 16 (2021)
Soham Shukla, Dhvani Shah, Alan A Martin, Nancy A Risebrough, Robyn Kendall, Claus F Vogelmeier, Isabelle H Boucot, Lee Tombs, Bjermer Leif, Paul W Jones, Edward M Kerwin, Chris Compton, Francois Maltais, David A Lipson, Afisi S Ismaila
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model. International journal of chronic obstructive pulmonary disease 16 (2021)
Leah B Sansbury, Robert P Wood, Glenn A Anley, Yein Nam, Afisi S Ismaila
Quantifying the Economic Impact of Delayed Multiple-Inhaler Triple Therapy Initiation in Patients with COPD: A Retrospective Cohort Study of Linked Electronic Medical Record and Hospital Administrative Data in England. International journal of chronic obstructive pulmonary disease 16 (2021)
Ike Iheanacho, Shiyuan Zhang, Denise King, Maria Rizzo, Afisi S Ismaila
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. International journal of chronic obstructive pulmonary disease 15 (2020)
Shiyuan Zhang, Denise King, Virginia M Rosen, Afisi S Ismaila
Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review. International journal of chronic obstructive pulmonary disease 15 (2020)
Melanie Schroeder, Nicole Benjamin, Laura Atienza, Chandroday Biswas, Alan A Martin, John D Whalen, José Luis Izquierdo Alonso, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Alicia Huerta, Afisi S Ismaila
Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective. International journal of chronic obstructive pulmonary disease 15 (2020)
Hannah B Lewis, Melanie Schroeder, Necdet B Gunsoy, Ellen M Janssen, Samuel Llewellyn, Helen A Doll, Paul W Jones, Afisi S Ismaila
Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany. International journal of chronic obstructive pulmonary disease 15 (2020)
Victoria Federico Paly, Ian P Naya, Necdet B Gunsoy, Maurice T Driessen, Nancy A Risebrough, Andrew Briggs, Afisi S Ismaila
Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study. International journal of chronic obstructive pulmonary disease 14 (2019)
Afisi S Ismaila, Nancy Risebrough, Melanie Schroeder, Dhvani Shah, Alan A Martin, Emma C Goodall, Kerigo Ndirangu, Gerard Criner, Mark Dransfield, David Mg Halpin, MeiLan K Han, David A Lomas
Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial. International journal of chronic obstructive pulmonary disease 14 (2019)
Dhvani Shah, Maurice Driessen, Nancy Risebrough, Timothy Baker, Ian Naya, Andrew Briggs, Afisi S Ismaila
Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective. Cost effectiveness and resource allocation : C/E 16 (2018)